Ling Wu and colleagues found through in vitro experiments that CGA can reprogram arachidonic acid metabolism by modulating the PTGS2/AKR1C3/GPX4 signaling pathway, thereby inducing ferroptosis to inhibit the proliferation, migration, and invasion of HCC cells (108). The gene discussed is PTGS2; the disease is hepatocellular carcinoma.